CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs
Condition(s):Drug-Related Side Effects and Adverse ReactionsLast Updated:May 20, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Drug-Related Side Effects and Adverse ReactionsLast Updated:May 20, 2016Completed
Condition(s):Vitamin K StatusLast Updated:December 19, 2023Terminated
Condition(s):HealthyLast Updated:February 12, 2013Completed
Condition(s):Multiple SclerosisLast Updated:August 25, 2022Recruiting
Condition(s):Atrial Fibrillation; Deep Vein Thrombosis; Pulmonary Embolism; Heart Valve DiseaseLast Updated:October 9, 2013Unknown status
Condition(s):Healthy Volunteers; Drug Drug InteractionsLast Updated:January 21, 2013Completed
Condition(s):Anticoagulation Treatment Overdose; Heart Valve DiseasesLast Updated:July 25, 2016Unknown status
Condition(s):Atrial Fibrillation; Venous Thromboses; Cardiac Valve DiseaseLast Updated:January 9, 2017Completed
Condition(s):Platelet FunctionLast Updated:December 15, 2023Terminated
Condition(s):Lamellar IchthyosisLast Updated:October 18, 2010Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.